Volume | 23,426 |
|
|||||
News | - | ||||||
Day High | 0.65 | Low High |
|||||
Day Low | 0.612 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.6298 | 0.612 | 0.65 | 0.6378 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
62 | 23,426 | $ 0.6452963 | $ 15,117 | - | 0.50 - 6.85 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:25:25 | 1 | $ 0.6375 | USD |
Phio Pharmaceuticals Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.51M | 2.44M | - | 0 | -10.83M | -4.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Phio Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.698 | 0.698 | 0.604849 | 0.6559002 | 44,590 | -0.048 | -6.88% |
1 Month | 0.81 | 0.81 | 0.604849 | 0.6986964 | 84,338 | -0.16 | -19.75% |
3 Months | 0.60 | 1.15 | 0.50 | 0.8448629 | 333,419 | 0.05 | 8.33% |
6 Months | 1.38 | 2.09 | 0.50 | 1.21 | 452,226 | -0.73 | -52.90% |
1 Year | 4.51 | 6.85 | 0.50 | 2.46 | 600,141 | -3.86 | -85.59% |
3 Years | 27.00 | 34.20 | 0.50 | 15.90 | 707,015 | -26.35 | -97.59% |
5 Years | 5.94 | 130.20 | 0.50 | 19.16 | 723,650 | -5.29 | -89.06% |
Phio Pharmaceuticals Description
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |